source
- STAT+: Top lawmaker takes aim at doctor lobby, linking AMA’s billing codes to fraud fightA top Republican is asking if the AMA's codes are helping to fuel health care fraud.
- Simlukafusp Alfa plus atezolizumab shows safety but no benefit over standard care in metastatic kidney cancerA clinical study evaluated the novel immunocytokine simlukafusp alfa combined with atezolizumab, with or without bevacizumab, in patients with unresectable metastatic renal cell carcinoma. The com…